SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-24-058720
Filing Date
2024-07-03
Accepted
2024-07-02 18:50:12
Documents
12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0208811-f3_immuron.htm F-3 514885
2 AT THE MARKET OFFERING AGREEMENT, DATED AS OF JULY 2, 2024, BY AND BETWEEN THE C ea020881101ex1-2_immuron.htm EX-1.2 223529
3 OPINION OF FRANCIS ABOURIZK LIGHTOWLERS, AUSTRALIAN COUNSEL TO IMMURON LIMITED ea020881101ex5-1_immuron.htm EX-5.1 40434
4 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea020881101ex5-2_immuron.htm EX-5.2 21182
5 CONSENT OF GRANT THORNTON AUDIT PTY LTD ea020881101ex23-1_immuron.htm EX-23.1 2373
6 FILING FEE TABLE ea020881101ex-fee_immuron.htm EX-FILING FEES 62327
7 GRAPHIC image_001.jpg GRAPHIC 4826
8 GRAPHIC ex5-1_001.jpg GRAPHIC 7109
9 GRAPHIC ex5-1_002.jpg GRAPHIC 27524
10 GRAPHIC ex5-1_003.jpg GRAPHIC 5430
11 GRAPHIC ex5-1_004.jpg GRAPHIC 12282
12 GRAPHIC ex5-2_001.jpg GRAPHIC 6272
  Complete submission text file 0001213900-24-058720.txt   953973
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-280667 | Film No.: 241097671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)